These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30378498)

  • 1. Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol.
    Bulva J; Simon RA
    Curr Vasc Pharmacol; 2019; 17(2):113-118. PubMed ID: 30378498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach.
    Vishnevsky A; Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):123-126. PubMed ID: 30058491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Clopidogrel Hypersensitivity without Interrupting Therapy: The Toronto Approach.
    Cheema AN
    Curr Vasc Pharmacol; 2019; 17(2):119-122. PubMed ID: 30124155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity.
    Ather A; Beavers CJ
    Curr Vasc Pharmacol; 2019; 17(2):127-132. PubMed ID: 30058492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel Hypersensitivity: Overview of the Problem.
    Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):108-109. PubMed ID: 30124153
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel Hypersensitivity: Pathogenesis, Presentation and Diagnosis.
    Ford MK; Cohn JR
    Curr Vasc Pharmacol; 2019; 17(2):110-112. PubMed ID: 30381080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
    Fajt M; Petrov A
    Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization to clopidogrel: a tailor-made protocol.
    Barreira P; Cadinha S; Malheiro D; Moreira da Silva JP
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):53-5. PubMed ID: 24702878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy.
    Page NA; Schroeder WS
    Ann Pharmacother; 2007 Jan; 41(1):61-7. PubMed ID: 17200429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
    Walker NE; Fasano MB; Hobbs RA; Horwitz PA
    Crit Pathw Cardiol; 2007 Mar; 6(1):26-9. PubMed ID: 17667884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
    J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization to prasugrel: cardiology's increased need for allergy consultation.
    Mutnick JL
    Ann Allergy Asthma Immunol; 2012 Feb; 108(2):124-5. PubMed ID: 22289733
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
    Walker NE; Fasano MB; Horwitz PA
    J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial.
    Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH
    EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Zhou Y; Wang Y; Wu Y; Huang C; Yan H; Zhu W; Xu W; Zhang L; Zhu J
    BMC Cardiovasc Disord; 2017 Jun; 17(1):157. PubMed ID: 28619104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prasugrel in a patient with clopidogrel hypersensitivity.
    Peppard SR; Held-Godgluck BM; Beddingfield R
    Ann Pharmacother; 2011 Oct; 45(10):e54. PubMed ID: 21896923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel use in a patient allergic to clopidogrel: effect of a drug shortage on selection of dual antiplatelet therapy.
    Felix-Getzik E; Sylvia LM
    Am J Health Syst Pharm; 2013 Mar; 70(6):511-3. PubMed ID: 23456404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching between P2Y
    Capranzano P; Capodanno D
    Vascul Pharmacol; 2019 May; 116():4-7. PubMed ID: 30876967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic reactions to clopidogrel and cross-reactivity to other agents.
    Lokhandwala J; Best PJ; Henry Y; Berger PB
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):52-7. PubMed ID: 20941557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.